In the BioHarmony Drug Report Database

"Preview" Icon

Tadalafil

Adcirca, Cialis, Tadalafil Lilly (tadalafil) is a small molecule pharmaceutical. Tadalafil was first approved as Adcirca on 2002-11-12. It is used to treat pulmonary hypertension and vasculogenic impotence in the USA. It has been approved in Europe to treat erectile dysfunction and pulmonary hypertension. The pharmaceutical is active against cGMP-specific 3′,5′-cyclic phosphodiesterase. In addition, it is known to target dual 3′,5′-cyclic-AMP and -GMP phosphodiesterase 11A.

 

Trade Name

 

Adcirca, Cialis, Tadalafil Lilly, Tadalafil Lilly
 

Common Name

 

tadalafil
 

ChEMBL ID

 

CHEMBL779
 

Indication

 

erectile dysfunction, pulmonary hypertension, vasculogenic impotence
 

Drug Class

 

Pde5 inhibitors

Image (chem structure or protein)

Tadalafil structure rendering